Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a major worldwide health problem. Recent studies suggest that the gut microbiota influences NAFLD pathogenesis. Here, a murine model of high-fat diet-induced (HFD-induced) NAFLD was used, and the effects of alterations in the gut microbiota on NAFLD were determined. Mice treated with antibiotics or tempol exhibited altered bile acid composition, with a notable increase in conjugated bile acid metabolites that inhibited intestinal farnesoid X receptor (FXR) signaling. Compared with control mice, animals with intestine-specific Fxr disruption had reduced hepatic triglyceride accumulation in response to a HFD. The decrease in hepatic triglyceride accumulation was mainly due to fewer circulating ceramides, which was in part the result of lower expression of ceramide synthesis genes. The reduction of ceramide levels in the ileum and serum in tempol- or antibiotic-treated mice fed a HFD resulted in downregulation of hepatic SREBP1C and decreased de novo lipogenesis. Administration of C16:0 ceramide to antibiotic-treated mice fed a HFD reversed hepatic steatosis. These studies demonstrate that inhibition of an intestinal FXR/ceramide axis mediates gut microbiota-associated NAFLD development, linking the microbiome, nuclear receptor signaling, and NAFLD. This work suggests that inhibition of intestinal FXR is a potential therapeutic target for NAFLD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hence, treatment with antibiotics ameliorates high-fat-diet-induced NAFLD in mice55.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [55]
In the citing paper
“Conversely, some data also indicate that antagonism of intestinal FXR signaling could improve metabolic parameters in murine models of NAFLD [256,257].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [257]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · cited 1×
“FXR, the central sensor and regulator for the biosynthesis and enterohepatic recycling of bile acids, plays a pivotal role in the control of lipid metabolism (42–45).”
Self-citation
Research works printed but not linked: 1
- 10.1172/jci21025 · DOI · Paper page
Cited by
Items 701–746 of 746
陳, 卓. (2020) · Institutional Repositories DataBase (IRDB)
非アルコール性脂肪性肝炎の病態進行における胆汁酸動態に関する研究
須賀, 隆. (2019) · Institutional Repositories DataBase (IRDB)
Spinelli, V. (2015) · theses.fr (ABES) · doi:10.70675/a86e63d5zbe7bz4510zbec4zdb4a29199701
Implications du microbiote intestinal et de la pectine dans la stéato-hépatite non-alcoolique
Houron, C. (2020) · theses.fr (ABES) · doi:10.70675/282e9d85z4f3dz4f5bz9045zd1ce6da72037
Rôle de LECT2 dans les maladies stéatosiques non alcooliques du foie
Pham, S. (2020) · theses.fr (ABES) · doi:10.70675/3693bfe6z9d91z4045za9a9zc37497dc9c1b
La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708
Rôle des sphingolipides hépatiques dans la physiopathologie du diabète de type 2
Lachkar, F. (2022) · theses.fr (ABES) · doi:10.70675/2f1ce169zade5z47ccz96caz55bf77edab09
Chang, D., McTigue, D. M., & Bruno, R. S. (2026) · Nutrition Research · doi:10.1016/j.nutres.2026.04.003
Chen, L., Liu, H., Chen, Y., Xiao, Q., Huang, Z., Li, Z., Zhang, X., Fan, X., Xiao, M., Li, X., et al. (2026) · Food & Function · doi:10.1039/d5fo04996b
Prakash, C., Garg, K., Deb, N., & Sinha, M. (2026) · International Journal of Current Pharmaceutical Review and Research · doi:10.25258/ijcpr.18.1.265
The Role of Gut Flora in the Formation of Gallstones
Goyal, S., & Goyal, S. (2026) · Haryana Journal of Surgery · doi:10.4103/hjs.hjs_1_26
Lou, Y., & Wang, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1849889
The bile acid-gut microbiota-vitamin D axis: new insights into biliary atresia
Huang, C., Li, Z., Shen, W., Luo, M., & 林发全 (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1847110
Liu, Y., Wang, J., Zhang, C., Li, Z., Nie, Y., Hu, Y., Liu, C., & Tu, Y. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08648-3
Hyodeoxycholic acid ameliorates tacrolimus-induced diabetes by modulating the FXR-FGF15 axis
Hu, N., Qian, M., Liu, Y., Jiang, Z., Xu, C., Zhang, W., & Jiang, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1865237
Du, Y., Qi, L., Shi, Y., Huang, X., Shi, X., Liu, M., Fang, Y., & Hu, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1912000
Wu, H., Zhou, L., Lin, W., Zhang, H.-X., Zhang, Z.-Q., Wang, X., Shi-ru, J., Liu, Z.-G., & Hu, F. (2026) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-026-00926-1
Bile acid-based therapeutics: recent advances in bile acid conjugates and derivatives
Seo, M., Lee, J.-H., Yang, S.-B., Ma, G., Lee, H., Han, J., Ryu, Y., & Park, J. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00830-5
Ye, X., Zhuofan, L. U., ZHANG, W., Xuelian, L. I. U., & ZHENG, H. (2026) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2026-0306
Manodara, G. (2024) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney)
Shen, Y., Cai, X., 郑怀军, Zheng, Z., Wu, L., Yuan, M., Jin, X., Ye, D., & Feng, Y. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.103036
Jiang, J., Xu, J., Wu, T., Chen, H., Zhu, W., Liu, Y., Liu, J., Yang, J., Xu, D., & Zhao, H. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.104056
BindingDB (2021) · UC San Diego · doi:10.7270/q2dj5jxg
Crosstalk along the gut–liver axis in liver disease: Clinical and mechanistic aspects
Nakamoto, N., Okada, H., Bäckhed, F., Schnabl, B., & Hov, J. R. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.10.019
Chen, Y., Li, Y., Li, X., Xu, X., & Chen, S. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1962509
Gao, Y., Gao, X., Wang, K., Qiao, J., & Jiang, C. (2026) · Science China Life Sciences · doi:10.1007/s11427-026-3413-3
Self-citationFood-Grade Kappa-Carrageenan Induces Liver Injury through the FXR/FGF15 Pathway in Mice
Zhu, S., Guo, X., Du, H., Luo, M., Xiao, H., & Han, Y. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c07572
Wang, K., Xing, Y., Ma, X., Jin, Y., 张会丰, & Yan, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.2007004
Abdalqadir, N. (2024) · TSpace (University of Toronto)
Dynamic zonal identity is a functional determinant of liver diseasePreprint
Yasaka, T., Inada, H., Kim, C., Singh‐Varma, A., Hu, S. P., Lehrich, B. M., Min, L., Poddar, M., Jain, A., Meadows, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.10.765616
Wu, L., Liu, X., Zhang, A., Chen, H., Zhao, R., & Jia, Y. (2023) · doi:10.3389/fvets.2023.1147024.s001
Zhang, N., Liu, J., Chen, Z., Chen, N., Gu, F., & He, Q. (2022) · doi:10.3389/fmicb.2022.832915.s001
Li, X., Suo, J., Huang, X., Dai, H., Bian, H., Zhu, M., Lin, W., & Han, N. (2021) · doi:10.3389/fnut.2021.761727.s001
Liu, Y., Tan, Y., Huang, J., Wu, C., Fan, X., Stalin, A., Lu, S., Wang, H., Zhang, J., Zhang, F., et al. (2023) · doi:10.3389/fphar.2022.875700.s007
Zhang, X., Diao, P., Yokoyama, H., Inoue, Y., Tanabe, K., Wang, X., Hayashi, C., Yokoyama, T., Zhang, Z., Hu, X., et al. (2022) · doi:10.3389/fnut.2022.852767.s001
Self-citationZhang, L., Hu, Y., An, Y., Wang, Q., Liu, J., & Wang, G. (2022) · doi:10.3389/fendo.2022.677202.s001
Self-citationLiu, L., Zhang, B., Sang, K., Lin, J., Li, M., Zhong, P., Lai, J., Xu, L., Chen, L., Liu, Y., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.2011401
Li, Y., & Liu, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1990233
Metadata
- Authors
- Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., Tanaka, N., Desai, D., Amin, S. G., Albert, I., Patterson, A. D., & Gonzalez, F. J.
- Affiliations
- National Institutes of Health (US)
- Pennsylvania State University (US)
- Corresponding author
- Patterson, Andrew D.
- Gonzalez, Frank J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-12-15
- Volume
- 125
- Issue
- 1
- Pages
- 386-402
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4382255
- OpenAlex
- W2124025733
- Cited by
- 693
- References
- 68
- Citations by year
- 2026: 43 · 2025: 52 · 2024: 52 · 2023: 61 · 2022: 76 · 2021: 84 · 2020: 70 · 2019: 63 · 2018: 58 · 2017: 61 · 2016: 46 · 2015: 26
- FWCI
- 33.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (R01ES022186, ES022186)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- non-alcoholic fatty liver disease, gut microbiota, bile acids, bile acid conjugates, ceramide, ceramide synthesis, SREBP-1c, de novo lipogenesis, hepatic steatosis, high-fat diet, antibiotic therapy, tempol, nuclear receptor signaling, therapeutic target
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Anti-Bacterial Agents, Bile Acids and Salts, Cecum, Gene Expression Regulation, Humans, Ileum, Liver, Male, Mice, Inbred C57BL, Mice, Transgenic, Gene Expression, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Metabolic Networks and Pathways, Diet, High-Fat, Mitochondrial Dynamics, Microbiota, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.